Efficacy of rituximab in patients with systemic sclerosis

Completed

• Conditions: Systemic sclerosis (SSc); Skin and Connective Tissue Diseases; Systemic sclerosis

• Registration Number: ISRCTN99672071
• Lead Sponsor: niversity Hospital of Patras (Greece)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-10-30
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 15

Inclusion Criteria

1. Both males and females
2. Detection of anti-Scl-70 autoantibodies in their sera
3. Presence of SSc-associated interstitial lung disease (ILD) as indicated by findings in either high-resolution computed tomography (HRCT) of the chest or pulmonary function tests (PFT) or both
4. Absence of any changes in medications and/or dosage of treatment administered during the last 12 months before enrolment

Exclusion Criteria

Aged less than 18 years

Study & Design

• Study Type: Interventional
• Study Design: Not specified